BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 3rd Quarter - Report

MEDICINES COMPANY

via JOHN LAMPMANN

3rd Quarter (July 1 - Sep 30) · 2010Posted Oct 31, 2010Filing document ↗LDA record ↗

Income$50Kfee reported

Client

Name: MEDICINES COMPANY
Location: United States of America

Registrant

Firm: JOHN LAMPMANN
Description: Consultant
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Copyright/Patent/Trademark
H.R. 1778
LobbyistsJOHN LAMPMANN
TargetedHOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

MEDICINES COMPANY — Lobbying — Receipts Report